Amgen Announces Award for Science Teaching Excellence in California Read more about Amgen Announces Award for Science Teaching Excellence in California
Amgen Submitted New Drug Applicatioin for Cinacalcet HCI Read more about Amgen Submitted New Drug Applicatioin for Cinacalcet HCI
Amgen Announces Webcast of First Quarter Financial Results Read more about Amgen Announces Webcast of First Quarter Financial Results
Sensipar Pivotal Studies in over 700 Patients Published in New England Journal of Medicine Read more about Sensipar Pivotal Studies in over 700 Patients Published in New England Journal of Medicine
Immunomedics Regains North American Development Rights from Amgen for Epratuzumab Read more about Immunomedics Regains North American Development Rights from Amgen for Epratuzumab
Amgen Names Rodger Currie Vice President, Government Affairs Read more about Amgen Names Rodger Currie Vice President, Government Affairs
FDA APPROVES ENBREL AS FIRST THERAPY TO INHIBIT BONE AND JOINT DAMAGE IN PSORIATIC ARTHRITIS PATIENTS Read more about FDA APPROVES ENBREL AS FIRST THERAPY TO INHIBIT BONE AND JOINT DAMAGE IN PSORIATIC ARTHRITIS PATIENTS
Amgen Foundation Gives $8 Million in Grants in 2002 Read more about Amgen Foundation Gives $8 Million in Grants in 2002
